Statins, PPIs Lead Chronic Drug Classes In Part D “Induced Demand”
Demand for statins and proton pump inhibitors showed solid gains among Medicare Part D enrollees in 2006, according to a recently released 1report from IMS Health
You may also be interested in...
BOSTON - Despite a strong start to 2007, growth in the pharmaceutical sector is expected to slow for the remainder of the year. According to IMS Health VP-Industry Relations Doug Long, "2007 has been a year that you could characterize as a fast start, slow finish.
Proposed class action lawsuit by Blue Cross Blue Shield of Minnesota against Vyera Pharmaceuticals could set a precedent for other health insurer actions against manufacturers.